UCSF researchers recently created the world's first shape-shifting synthetic proteins using artificial intelligence (AI). The breakthrough opens the door to developing entirely new proteins that could ...

The global Biosimilars Market , valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to ...

Recombinant DNA and the ability to import heterologous genes and whole pathways to the desired host cell offered the opportunity to consolidate in a single cell what was previously being ...

Recombinant therapeutics market surges to $960.4B by 2035, fueled by biotech advances, targeted therapies, and rising global ...

Glucose-stimulated as well as self-limiting insulin production was achieved in vector-transduced hepatoma cells in which expression of the insulin gene was controlled by the G6Pase promoter.

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

In a bold move to redefine the future of human performance and wellbeing, MAXIOM Labs and DNAthlete AG today announced a strategic partnership to combine DNA ...

DNA and genealogy tools recently reunited Melissa Highsmith with her family after 51 years, showing how tech is changing outcomes for missing persons and murder cases.

As the nation mourns the victims of the devastating Air India crash in Ahmedabad, science is quietly stepping in to offer solace to grieving families.

Irving Police said new DNA technology helped solve a three decades old cold case and arrest a former neighbor for the 1994 murder of Megan Johns.

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s ...